Gelucire-Based Nanoparticles for Curcumin Targeting to Oral Mucosa: Preparation, Characterization, and Antimicrobial Activity Assessment

Journal of Pharmaceutical Sciences

Volumn 104, Issue 11, 2015, Pages 3913-3924

  Hazzah, Heba A ^a   Farid, Ragwa M ^a   Nasra, Maha M A ^b   Hazzah, Walaa A ^c   El Massik, Magda A ^a   Abdallah, Ossama Y ^b  

^a Pharos University of Alexandria   (Egypt)

^b Alexandria University Faculty of Pharmacy   (Egypt)

^c High Institute of Public Health Egypt   (Egypt)

Author keywords

antimicrobial activity; buccal; cell disintegration; curcumin; drug delivery system; lipid; mucosal delivery; nanoparticles

Indexed keywords

CURCUMIN; GELUCIRE; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; POLOXAMER; SOLID LIPID NANOPARTICLE; STABILIZING AGENT; ANTIINFECTIVE AGENT; DRUG CARRIER; LIPID; NANOPARTICLE;

ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CANDIDA ALBICANS; CHEEK MUCOSA; CONTROLLED STUDY; CRYSTALLIZATION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; ESCHERICHIA COLI; EX VIVO STUDY; EXPERIMENTAL CHICKEN; HYDROGEN BOND; IN VITRO STUDY; LACTOBACILLUS ACIDOPHILUS; LIPID SOLUBILITY; MELTING POINT; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUTH CAVITY; MOUTH MUCOSA; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS; SUPERNATANT; THERMOGRAPHY; TISSUE HOMOGENATE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; CHEMISTRY; CHICKEN; DRUG EFFECTS; FUNGUS; METABOLISM; MICROBIOLOGY; MYCOSES;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; CHICKENS; CURCUMIN; DRUG CARRIERS; FUNGI; LIPIDS; MOUTH MUCOSA; MYCOSES; NANOPARTICLES;

EID: 84944174360     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24590     Document Type: Article

References (51)

1. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu W-H, Lakshmanan A, Wade WG,. 2010. The human oral microbiome. J Bacteriol 192 (19): 5002-5017.
2. Bonifácio BV, da Silva PB, dos Santos Ramos MA, Negri KMS, Bauab TM, Chorilli M,. 2014. Nanotechnology-based drug delivery systems and herbal medicines: A review. Int J Nanomedicine 9: 1-15.
3. Khanna N,. 1999. Turmeric-Nature's precious gift. Curr Sci 76 (10): 1351-1356.
4. Gupta SC, Kim JH, Prasad S, Aggarwal BB,. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29 (3): 405-434.
5. Prasad S, Tyagi AK, Aggarwal BB,. 2014. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res Treat 46 (1): 2-18.
6. Tomren M, Masson M, Loftsson T, Tønnesen HH,. 2007. Studies on curcumin and curcuminoids: XXXI. Symmetric and asymmetric curcuminoids: Stability, activity and complexation with cyclodextrin. Int J Pharm 338 (1): 27-34.
7. Kunnumakkara AB, Anand P, Aggarwal BB,. 2008. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269 (2): 199-225.
8. Karavana SY, Gökçe EH, Rençber S, Özbal S, Pekçetin Ç, Güneri P, Ertan G,. 2012. A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: In vivo/in vitro examinations. Int J Nanomedicine 7: 5693.
9. Hosny KM, Aljaeid BM,. 2014. Sildenafil citrate as oral solid lipid nanoparticles: A novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction. Expert Opin Drug Deliv (0): 1-8.
10. Apaolaza PS, Delgado D, Pozo-Rodríguez Ad, Gascõn AR, Solinís M,. 2014. A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases. Int J Pharm 465 (1): 413-426.
11. Bhatt R, Singh D, Prakash A, Mishra N,. 2014. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease. Drug Deliv (0): 1-9. http://informahealthcare.com.sci-hub.org/doi/pdf/10.3109/10717544.2014.880860
12. Mishra D, Mishra H, Mishra PK, Nahar M, Dubey V, Jain NK,. 2010. Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route. J Pharm Pharm Sci 13 (4): 495-509.
13. Shah KA, Date AA, Joshi MD, Patravale VB,. 2007. Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery. Int J Pharm 345 (1): 163-171.
14. Gomes MJ, Martins S, Ferreira D, Segundo MA, Reis S,. 2014. Lipid nanoparticles for topical and transdermal application for alopecia treatment: Development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine 9: 1231-1242.
15. Han SB, Kwon SS, Jeong YM, Yu ER, Park SN,. 2014. Physical characterization and in vitro skin permeation of solid lipid nanoparticles for transdermal delivery of quercetin. Int J Cosmet Sci 36 (6): 588-597.
16. Kakkar V, Singh S, Singla D, Kaur IP,. 2011. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 55 (3): 495-503.
17. Kakkar V, Muppu SK, Chopra K, Kaur IP,. 2013. Curcumin loaded solid lipid nanoparticles: An efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm 85 (3): 339-345.
18. Sun J, Bi C, Chan HM, Sun S, Zhang Q, Zheng Y,. 2013. Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability. Colloids Surf B: Biointerfaces 111: 367-375.
19. Shimpi SL, Mahadik KR, Paradkar AR,. 2009. Study on mechanism for amorphous drug stabilization using Gelucire 50/13. Chem Pharm Bull 57 (9): 937-942.
20. Tsai M-J, Wu P-C, Huang Y-B, Chang J-S, Lin C-L, Tsai Y-H, Fang J-Y,. 2012. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 423 (2): 461-470.
21. Padhye S, Nagarsenker MS,. 2013. Simvastatin solid lipid nanoparticles for oral delivery: Formulation development and in vivo evaluation. Indian J Pharm Sci 75 (5): 591-598.
22. Sangsen Y, Likhitwitayawuid K, Sritularak B, Wiwattanawongsa K, Wiwattanapatapee R,. 2013. Novel solid lipid nanoparticles for oral delivery of oxyresveratrol: Effect of the formulation parameters on the physicochemical properties and in vitro release. Int J Med Pharm Sci Eng 7 (12): 506-513.
23. El-Refaie WM, Elnaggar YS, El-Massik MA, Abdallah OY,. 2015. Novel curcumin-loaded gel-core hyaluosomes with promising burn-wound healing potential: Development, in-vitro appraisal and in-vivo studies. Int J Pharm 486 (1): 88-98.
24. Peppas N,. 1984. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60 (4): 110-111.
25. Siepmann J, Siepmann F,. 2008. Mathematical modeling of drug delivery. Int J Pharm 364 (2): 328-343.
26. das Neves J, Bahia MF, Amiji MM, Sarmento B,. 2011. Mucoadhesive nanomedicines: Characterization and modulation of mucoadhesion at the nanoscale. Expert Opin Drug Deliv 8 (8): 1085-1104.
27. El-Samaligy M, Afifi N, Mahmoud E,. 2006. Increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation. Int J Pharm 308 (1): 140-148.
28. Madsen KD, Sander C, Baldursdottir S, Pedersen AML, Jacobsen J,. 2013. Development of an ex vivo retention model simulating bioadhesion in the oral cavity using human saliva and physiologically relevant irrigation media. Int J Pharm 448 (2): 373-381.
29. Patel VF, Liu F, Brown MB,. 2012. Modeling the oral cavity: In vitro and in vivo evaluations of buccal drug delivery systems. J Control Release 161 (3): 746-756.
30. Forbes BA, Sahm D, Weissfeld A,. 2005. Diagnostic microbiology. Bailey and Scott's Diagnostic Microbiology, St. Louis Mosby ElSevier.
31. Date AA, Vador N, Jagtap A, Nagarsenker MS,. 2011. Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: Fabrication, characterization and evaluation for oral drug delivery. Nanotechnology 22 (27): 1-12.
32. Jeon HS, Seo JE, Kim MS, Kang MH, Oh DH, Jeon SO, Jeong SH, Choi YW, Lee S,. 2013. A retinyl palmitate-loaded solid lipid nanoparticle system: Effect of surface modification with dicetyl phosphate on skin permeation in vitro and anti-wrinkle effect in vivo. Int J Pharm 452 (1): 311-320.
33. Bourezg Z, Bourgeois S, Pressenda S, Shehada T, Fessi H,. 2012. Redispersible lipid nanoparticles of spironolactone obtained by three drying methods. Colloids Surf A: Physicochem Eng Aspects 413: 191-199.
34. Shah R, Eldridge D, Palombo E, Harding I,. 2014. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys Sci 25 (1): 59-75.
35. Kumar PP, Gayatri P, Sunil R, Jagamohan S, Rao YM,. 2012. Atorvastatin loaded solid lipid nanoparticles: Formulation, optimization, and in vitro characterization. IOSR J Pharm 2 (5): 23-32.
36. BASF. 2010. Technical information-"Lutrol L, Lutrol F Grades". Accessed, at: http://www.pharma-ingredients.basf.com/Statements/Technical%20Informations/EN/Pharma%20Solutions/03-100102e-Lutrol%20L%20and%20Lutrol%20F-Grades.pdf. Accessed on March 01, 2015.
37. Qi H, Chen W, Huang C, Li L, Chen C, Li W, Wu C,. 2007. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 337 (1): 178-187.
38. Albertini B, Passerini N, Di Sabatino M, Monti D, Burgalassi S, Chetoni P, Rodriguez L,. 2010. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: Formulation, manufacturing and characterization. Int J Pharm 399 (1): 71-79.
39. Monti D, Burgalassi S, Rossato M, Albertini B, Passerini N, Rodriguez L, Chetoni P,. 2010. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part II: In vitro/in vivo evaluation. Int J Pharm 400 (1): 32-36.
40. Jones DS, Bruschi ML, de Freitas O, Gremião MPD, Lara EHG, Andrews GP,. 2009. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. Int J Pharm 372 (1): 49-58.
41. Yuan Y, Cui Y, Zhang L, Zhu H-p, Guo Y-S, Zhong B, Hu X, Zhang L, Wang X-h, Chen L,. 2012. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Int J Pharm 430 (1): 114-119.
42. Lin H, Gebhardt M, Bian S, Kwon K, Shim C-K, Chung S-J, Kim D-D,. 2007. Enhancing effect of surfactants on fexofenadine HCl transport across the human nasal epithelial cell monolayer. Int J Pharm 330 (1): 23-31.
43. Wang Y-J, Pan M-H, Cheng A-L, Lin L-I, Ho Y-S, Hsieh C-Y, Lin J-K,. 1997. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15 (12): 1867-1876.
44. Khairy HM,. 2014. Development and evaluation of some drug delivery systems to the oral cavity. Master's thesis., Alexandria, Egypt: University of Alexandria.
45. Dziemiańczyk D, Grabowska S, Balicki R,. 2005. Evaluation of secretory mucin concentration of patients with squamous cell carcinoma oral cavity. Rocz Akad Med Bialymst 50: 334-338.
46. Sinha VR, Srivastava S, Goel H, Jindal V,. 2011. Solid lipid nanoparticles (SLN's)-Trends and implications in drug targeting. Int J Adv Pharm Sci 1 (3): 212-238.
47. Neelofar K, Shreaz S, Rimple B, Muralidhar S, Nikhat M, Khan LA,. 2011. Curcumin as a promising anticandidal of clinical interest. Can J Microbiol 57 (3): 204-210.
48. Song J, Choi B, Jin E-J, Yoon Y, Choi K-H,. 2012. Curcumin suppresses Streptococcus mutans adherence to human tooth surfaces and extracellular matrix proteins. Eur J Clin Microbiol Infect Dis 31 (7): 1347-1352.
49. Basniwal RK, Buttar HS, Jain V, Jain N,. 2011. Curcumin nanoparticles: Preparation, characterization, and antimicrobial study. J Agric Food Chem 59 (5): 2056-2061.
50. Hube B, Stehr F, Bossenz M, Mazur A, Kretschmar M, Schäfer W,. 2000. Secreted lipases of Candida albicans: Cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch Microbiol 174 (5): 362-374.
51. Kumar A, Dhamgaye S, Maurya IK, Singh A, Sharma M, Prasad R,. 2014. Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans. Antimicrob Agents Chemother 58 (1): 167-175.